Swisspartners Ltd. Bio N Tech Se Transaction History

Swisspartners Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$123.25 - $186.24 $12,325 - $18,624	100 Added 2.65%	3,880 $597,000
Q1 2022 May 11, 2022	SELL	$126.25 - $231.85 $1.73 Million - $3.18 Million	-13,720 Reduced 78.4%	3,780 $645,000
Q1 2022 May 04, 2022	BUY	$126.25 - $231.85 $2.07 Million - $3.81 Million	16,420 Added 1520.37%	17,500 $5.3 Million
Q4 2021 Feb 09, 2022	BUY	$216.64 - $362.52 $233,971 - $391,521	1,080 New	1,080 $282,000

357

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $29.3B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Swisspartners Ltd., based on Form 13F filings with the SEC.

Stay updated on Swisspartners Ltd. with notifications on news.